TNYA — Tenaya Therapeutics Balance Sheet
0.000.00%
- $294.99m
- $223.32m
- 24
- 18
- 86
- 37
Annual balance sheet for Tenaya Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 129 | 251 | 187 | 105 | 61.4 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 130 | 255 | 194 | 112 | 67.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17.2 | 54.7 | 62.7 | 53.3 | 47.7 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 148 | 314 | 279 | 171 | 120 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.04 | 21.8 | 24.2 | 22.7 | 16 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.72 | 35.7 | 35.6 | 31.1 | 27.1 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 139 | 279 | 243 | 139 | 92.9 |
| Total Liabilities & Shareholders' Equity | 148 | 314 | 279 | 171 | 120 |
| Total Common Shares Outstanding |